The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
There's a hole in the bucket Dear Liza Dear Liza.............Drip Drip until its empty. Cash at the Bank does not impress the market. Its the use of that cash and future profitability that convinces. None of these are apparent.
Hope Springs Eternal.
DRB, transparency on Nova do not go together. The CEO is simply non existent and communications horrendous. DHSC issue will not be resolved one way or another anytime soon. Just generic talk about future "plans" which the market is not buying. I have stated before that i have sold my shares and intended to buy again. But certainly not in these circumstances. Will wait by the sidelines for the moment. But not expecting any "miracle"
TIM who ?? Only a ghost.
Dr Zed The consolidation process goes hand in hand with a lower SP prior to consolidation. Have seen it happen numerous times. SP will rise only if there is a clear pathway . For now we are nowhere near a catalyst which would justify further appreciation . I remain an LTH having an average price of 2p but remain feet firmly on the ground. There are no guarantees and cannot rule out that in spite of the science and prospects there will be delays .
A level headed assessment RMM.
Jaceorge, agree. Let's call a spade a spade.
What massive blue trades.???? More sellers than buyers. and SP movement no surprise as news is least 6 months away. No MM manipulation just investors not willing to wait. Deja vu. Can go back to the 2p level at this rate.
Taverham, it is well that we forget about Porky. Mislead many investors. Don't miss him at all
Look forward to that Casper.
Aberystwyth as you so correctly quoted " potential best in class.....potential multi billion sales....potential better asset.. "
There is a chasm between potential and reality or certainty. Not even started clinical trials. So the price appreciation to the present SP of around 5p amply reflects this " potential". Many months away from having some tangible news. Willing to wait but i do not expect any fireworks for now. Coverage by analysts in my view is dire . Do not expect any guidance from BOD for now as realistically there is little else to report except what is already known. Still high risk/high return situation which is normal for this kind of AIM share and particularly in the biotech sector. I hold and will continue to hold Sareum but my expectations are a bit more down to earth. Certainly not de ramping.
Nothing is "easy" SPURS 312. I admire your enthusiasm but at the same time you are advocating another 10% down. Feet on the ground. We are at least 6 months away from any tangible news. Firm belief in the science but also accept that there are risks which are normal to the sector.
That i did Wilson 63, if you don't mind. Do i need your permission to stay on this BB.?
Exactly " waiting and seeing how much grass its been chewing" And here lies the market doubt amongst other factors. No progress reports from company. Complete silence which gives rise to negative vibes and speculation. Talk by CEO to grow company into a mid cap is futile unless you build momentum supported by facts.
BrentW1 the market knows something ordinary holders don't know. All this talk about shorters etc etc is peripheral. Market is heading towards valuing the company only for its cash at bank. Everything else is hazy and unclear and absolutely no sense of direction from the BOD. The CEO silence speaks volumes. He is also at a loss it seems. Novacyt is simply "another " diagnostic company as tens and tens of others. No market advantage and not in the good books of DHSC. Many other opportunities in the market.
Gunner the BOD will not comment on SP. This is AIM and expect wild fluctuations even on low volume. No prospect of takeover bid at this stage, way too early. We have to be patient and wait it out for next 6 months.
Moniman why should new CEO buy? Nothing attractive on the horizon no catalyst to revive SP. Out of favour with DHSC and no transparency as to future plans just generic chatter. The conspiracy theories on MM's have proven to be mostly unfounded. I was out last week. Will re enter if i see some tangible news which does not seem forthcoming. CEO will be able to buy, should he want to do so, at lower levels , at at this rate sub £2.
Pharmaguy the fall in SP is a reflection of the fact that no news is round the corner. Investors get cold feet and cash in when too optimistic projections fail to materialise. Expect price to drift for some months and bid/offer spread widening.
Mafuta investors who went in at much lower levels will want to take a profit. I would not consider selling at this stage but there are risks and nothing is a certainty. Delays will occur and setbacks for this kind of product is common.
Hi Brenda!!